Aortic Stenosis Market Is Estimated To Witness High Growth Owing To Rising Prevalence of Cardiovascular Diseases
![]() |
Aortic Stenosis Market |
The global Aortic Stenosis Market is estimated to be valued at US$14.18 billion in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Aortic stenosis is a medical condition characterized by the narrowing of the
aortic valve, which obstructs the blood flow from the left ventricle to the
aorta. This condition leads to the accumulation of pressure on the left
ventricle, eventually causing heart failure. The increasing prevalence of
cardiovascular diseases, particularly among the elderly population, is driving
the demand for effective diagnosis and treatment options for aortic stenosis.
Various medical devices and surgical procedures, such as transcatheter aortic
valve replacement (TAVR) and balloon valvuloplasty, are being developed and
adopted to address the growing need for managing aortic stenosis.
Market Key Trends:
One of the key trends in the Aortic Stenosis Market is the growing adoption of
transcatheter aortic valve replacement (TAVR) procedures. TAVR is a minimally
invasive procedure that involves replacing the damaged aortic valve with a
prosthetic valve through a catheter. This procedure offers several advantages
over traditional open-heart surgery, such as shorter hospital stays, faster
recovery times, and reduced risk of complications. As a result, TAVR is
increasingly being preferred by both patients and physicians. The development
of innovative and advanced TAVR devices, along with the expansion of TAVR into
low-risk patient populations, is expected to drive the growth of the Aortic
Stenosis Market during the forecast period.
PEST Analysis:
Political: The political landscape can have a significant impact on the Aortic
Stenosis Market. Government regulations and policies regarding healthcare and
medical devices can influence the market dynamics. For example, changes in
healthcare reimbursement policies may impact the affordability and
accessibility of treatment options for patients.
Economic: The economic factors play a crucial role in the growth of the Aortic
Stenosis Market. The market is expected to witness high growth, with a CAGR of
15% over the forecast period. This growth can be attributed to factors such as
increasing healthcare expenditure, rising prevalence of aortic stenosis, and
technological advancements in treatment options.
Social: The social factors influencing the Aortic Stenosis Market include
changing demographics and lifestyle habits. The aging population is more
susceptible to developing aortic stenosis, leading to a rising demand for
treatment options. Additionally, increasing awareness about cardiovascular
diseases and the importance of early diagnosis and treatment is driving market
growth.
Technological: Technological advancements play a vital role in the Aortic
Stenosis Market. Innovative treatment options such as transcatheter aortic
valve replacement (TAVR) are gaining popularity due to their minimally invasive
nature and improved patient outcomes. Advancements in imaging technologies and
diagnostic tools also contribute to early detection and better management of
aortic stenosis.
Key Takeaways:
The global
Aortic Stenosis Market is expected to witness high growth, exhibiting a
CAGR of 15% over the forecast period
(2023-2030). The market size for 2023 is estimated to be US$ 14.18 billion. This growth can be attributed to various
factors, including increasing healthcare expenditure, rising prevalence of
aortic stenosis, and technological advancements in treatment options.
Regionally, North America is expected to be the fastest-growing and dominating
region in the Aortic Stenosis Market. The region has a well-established
healthcare infrastructure, favorable reimbursement policies, and a high
prevalence of cardiovascular diseases. Additionally, increasing adoption of
minimally invasive treatment options and a growing geriatric population
contribute to the market's growth in this region.
Key players operating in the Aortic Stenosis Market include Edwards
Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific
Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomédica, JenaValve
Technology, Inc., Meril Life Sciences Pvt. Ltd., and Micro Interventional
Devices, Inc. These key players are involved in strategic initiatives such as
mergers and acquisitions, new product launches, and partnerships to expand
their market presence and gain a competitive edge.
Comments
Post a Comment